脊椎蛋白2(SPON2)重組蛋白
Recombinant Spondin 2 (SPON2)
DIL1; Mindin; M-spondin; Extracellular Matrix Protein; Differentially expressed in cancerous and non-cancerous lung cells 1
- 編號URPF396Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量53.1kDa
- 實際分子量54kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ser119~Val331 with N-terminal His and GST Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點5.6
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 516 ¥ 1290 ¥ 2580 ¥ 7740 ¥ 19350
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPF396Hu01 | 脊椎蛋白2(SPON2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAF396Hu01 | 脊椎蛋白2(SPON2)多克隆抗體 | IHC |
| UMAF396Hu21 | 脊椎蛋白2(SPON2)單克隆抗體 | WB; IHC; ICC; IP. |
| USEF396Hu | 脊椎蛋白2(SPON2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMF396Hu | 脊椎蛋白2(SPON2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| The Journal of Urology | Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer [Pubmed: 23665271] |
| Oxford Journals | SP136EVALUATION OF SERUM SPONDIN 2 LEVELS IN THE DIFFERENT ETIOLOGIES OF GLOMERULAR DISEASES [Content: 30] |
| Nephrology (Carlton) | Evaluation of Serum Spondin 2 Levels in the Different Stages of Type 2 Diabetic Nephropathy [PubMed: 25973958] |
| Oncogene | The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation [pubmed:28991232] |
| Endocrinology | Study of human T21 placenta suggests a potential role of mesenchymal spondin-2 in placental vascular development [Pubmed: 30715257] |
| Journal of Cellular and Molecular Medicine | Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice [Pubmed: 32614521] |
留言咨詢
